How Mesothelioma Differs from Lung Cancer
Mesothelioma and lung cancer can both affect the chest, yet they are not the same disease. Mesothelioma starts in the mesothelium, the thin lining around the lungs, abdomen, or heart. Lung cancer starts in lung tissue itself. That difference changes symptoms, tests, and treatment.
The most common form is pleural mesothelioma. It grows along the lining outside the lung, often as a sheet or rind. Lung cancer usually forms a mass inside the lung or airway. Therefore, a scan that shows a chest problem still needs a biopsy before doctors name the cancer.
Exposure history also separates the two. Asbestos is the main known cause of mesothelioma. Symptoms can appear decades after that exposure. Lung cancer has a wider set of causes. Smoking is the leading one. Radon, air pollution, and asbestos can also raise lung-cancer risk. Smoking does not play the same central role in mesothelioma. However, smoking plus asbestos sharply raises the risk of lung cancer.
Under the microscope, the cells do not match. Mesothelioma comes from mesothelial cells. Pathologists often group it as epithelioid, sarcomatoid, or biphasic. Lung cancer comes from airway or alveolar cells. Common types include adenocarcinoma, squamous cell carcinoma, and small cell lung cancer. Stain panels help separate them. Mesothelioma cells often mark with calretinin, WT1, and D2-40. Lung adenocarcinoma often marks with TTF-1 and napsin A. These results matter because the treatment path depends on the cell type.
Spread patterns differ too. Pleural mesothelioma tends to coat the chest lining and can trap fluid around the lung. Lung cancer more often spreads through lymph nodes and blood to the brain, bone, liver, or adrenal glands. Staging systems are also separate. A lung-cancer stage does not translate directly into a mesothelioma stage.
Treatment follows that split.
Lung-cancer care may include surgery, chemotherapy, radiation, targeted drugs, or immunotherapy, based on type and markers. Mesothelioma care may include chemotherapy, immunotherapy, fluid drainage, and surgery in selected patients. A drug that fits one diagnosis can be a poor fit for the other. Therefore, teams should not treat a pleural lining cancer as if it were a standard lung tumor.
The practical point is simple. Both diseases can cause breathlessness, chest pain, and cough. Location, cell origin, asbestos history, and lab markers still set them apart. Only tissue diagnosis should decide which name, and which plan, applies.
Disclaimer: This article explains general differences for information only. It is not a diagnosis, a prognosis, or medical advice. Test results and treatment choices should come from a qualified clinician and a pathology report.